510(k) · Cleared
ClearedFlostat Vascular Lab
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Biomedix, Inc. · JAF Monitor, Ultrasonic, Nonfetal
Cleared on Dec 23, 1997 after a 90-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 7 later devices descend from it.
- Decided
- Dec 23, 1997
- Review
- 90 days
- Class
- Class II
- Product code
- JAF
- Recalls
- None
- Predicates
- 0
7 later devices descend from it, 3 citing it directly.
- This deviceK973644 Flostat Vascular LabBiomedix, Inc. · 1997
- Descendant · cites it directly · 5 of its ownK042616 Biomedix Padnet LabBiomedix, Inc. · 2004
- Descendant · cites it directly · 2 of its ownK073146 Padnet+Biomedix, Inc. · 2007
- Descendant · 2 generations on · 1 of its ownK122281 Padnet 2.0Biomedix, Inc. · 2012
- Descendant · 3 generations on · 0 of its ownK220527 PADnet XpressCollaborative Care Diagnostics, LLC, D.B.A. Biomedix · 2022
- Descendant · 2 generations on · 0 of its ownK103693 Vantage AbiSummit Doppler Systems, Inc. · 2011
Showing 5 of 7 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 7 · See all- K042616Biomedix Padnet LabBiomedix, Inc. · 2004 · cites it directly5descendants
- K073146Padnet+Biomedix, Inc. · 2007 · cites it directly2descendants
- K122281Padnet 2.0Biomedix, Inc. · 2012 · 2 generations on1descendant
- K220527PADnet XpressCollaborative Care Diagnostics, LLC, D.B.A. Biomedix · 2022 · 3 generations on0descendants
- K103693Vantage AbiSummit Doppler Systems, Inc. · 2011 · 2 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K973644 | Flostat Vascular Lab | Biomedix, Inc. | 1997 | — |
| +1 | K042616 | Biomedix Padnet Lab | Biomedix, Inc. | 2004 | — |
| +1 | K073146 | Padnet+ | Biomedix, Inc. | 2007 | — |
| +2 | K122281 | Padnet 2.0 | Biomedix, Inc. | 2012 | — |
| +3 | K220527 | PADnet Xpress | Collaborative Care Diagnostics, LLC, D.B.A. Biomedix | 2022 | — |
| +2 | K103693 | Vantage Abi | Summit Doppler Systems, Inc. | 2011 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2001 | 1 | 0 |
| 2004 | 1 | 0 |
| 2007 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
| 2022 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in JAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new JAF device
- #1 K242487 Laminar P1 (LDH-HW-001)score 10.3 · 7 generations · no Class I recall
What was it cleared against?
FDA’s file for it is a 510(k) statement, which names no predicate.
What descends from it? (7)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K042616 (Biomedix, Inc., 2004) has gone furthest, with 5 descendants of its own.
How does its category compare?
All JAF devicesJAF Monitor, Ultrasonic, Nonfetal: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · JAF
1in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · JAF
Too few JAF 510(k)s in any year since 2007 to give a median.
Recalls per year · JAF
No recall names JAF since 2007.
Adverse event reports per year · JAF
1in 2023
MAUDE reports naming product code JAF, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 1 | — | 0 | 0 |
| 2009 | 2 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 1 |
| 2011 | 1 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 1 |
| 2013 | 0 | — | 0 | 2 |
| 2014 | 0 | — | 0 | 8 |
| 2015 | 1 | — | 0 | 7 |
| 2016 | 0 | — | 0 | 5 |
| 2017 | 0 | — | 0 | 44 |
| 2018 | 0 | — | 0 | 1 |
| 2019 | 0 | — | 0 | 2 |
| 2020 | 0 | — | 0 | 5 |
| 2021 | 0 | — | 0 | 1 |
| 2022 | 0 | — | 0 | 2 |
| 2023 | 0 | — | 0 | 1 |
| 2024 | 1 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The BioMedix, Inc. Flostat Vascular Lab is a device for the use in the diagnosis of the etiology and extent of vascular pathology primarily in the peripheral vasculature and, in a more restricted sense, in the central vasculature (periorbital region ONLY). These tasks are accomplished via three separate modalities, each of which can be use to test either the arterial or venous system. The three modalities are 1) Pneumoplethysmography (blood pressure cuff…
Read the full statement (475 words)
The BioMedix, Inc. Flostat Vascular Lab is a device for the use in the diagnosis of the etiology and extent of vascular pathology primarily in the peripheral vasculature and, in a more restricted sense, in the central vasculature (periorbital region ONLY). These tasks are accomplished via three separate modalities, each of which can be use to test either the arterial or venous system. The three modalities are 1) Pneumoplethysmography (blood pressure cuff air inflation), 2) Photoplethysmography (change in infrared light reflectance on skin as a reflection of larger branches) and 3) Simple continuous wave doppler ultrasound velocity waveform measurement. NONE of these testing modalities are intended for FETAL USE and the devices and instruction manuals are so labelled.
The air pump Pneumoplethysmograph and infrared Photoplethysmograph are for use in studying the PERIPHERAL VASCULATURE ONLY.
The 5 MHz. continuous wave doppler ultrasound velocity meter and the 8 MHz. continuous wave doppler ultrasound velocity meter are for use in studying the PERIPHERAL VASCULATURE ONLY.
There is a separate control setting labelled clearly on the FLOSTAT VASCULAR LAB - ‘Ophthalmic-8 MHz.’ doppler which is intended for periorbital doppler studies ONLY. The ‘Ophthalmic-8 MHz.’ mode is an 8 MHz. continuous wave doppler ultrasound velocity meter exactly the same as the 8 MHz. continuous wave doppler velocity meter except that the ‘Ophthalmic-8 MHz.’ doppler has substantially lower acoustic output which conforms to the safety standards for periorbital studies specified by the Food and Drug Administration (FDA). Through medical studies performed by the scientists at the FDA, it has been determined that ultrasound acoustic levels as rated by various figures of merit (eg ISPTA, etc.) are safe for different areas of the body.
For this reason, DO NOT EVER PERFORM PERIORBITAL STUDIES WITH THE DOPPLER IN ANY MODE OTHER THAN THE ‘Ophthalmic-8 MHz.’ MODE. Labels will also be placed on the doppler transducer that they are NOT FOR FETAL USE and specifying the correct frequency (5 MHz or 8 MHz).
The doppler section is intended to generate velocity waveforms and values for study and audio output for physician analysis of the arterial and venous system.
The Ultrasonic Doppler device at 5 MHz. and 8 MHz. applies ultrasound energy through the extremities of the subject to assess blood velocity, blood velocity waveform morphology, spectrum analysis, pressure, and patency of PERIPHERAL VESSELS.
The Ultrasonic Ophthalmic-8 MHz. device applies ultrasound energy to the periorbital region to assess blood velocity, blood velocity waveform morphology, and spectrum analysis in this area.
The Pneumoplethysmograph is used to gauge the arterial system through volume pulse recording studies and is used to gauge the venous system through maximum venous outflow studies.
The Photoplethysmograph is used to gauge the arterial system through pulse waveform analysis and is used to gauge the venous system through venous reflux time tests. Full clinical information is provided in the Operators Instruction Manual (enclosed herein).
Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K973644 · printed Nov 5, 2026
Cite this page
510(k) Report. “K973644: Flostat Vascular Lab.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K973644
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026